|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 13794110.0 (espacenet) (Federated) (European Patent Register), 20130524 | | Patent/reg. no. and date | DK/EP 2856149, 20200708 | | Publication date | 20150408 | | Priority no. and date | US 201261651144 P, 20120524 | | EP pub. no. and date |
EP 2856149 20150408 | | Effective date | | | Applicant/owner | Phaim Pharma Ltd, One Bartholomew Close
London
EC1A 7BL, GB | | Applicant ref. no. | P73790DK01 | | Inventor | ORBAN, Tihamer, 64 Aspinwall Avenue no.1
Brookline, MA 02446, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | G01N 33/48 (2006.01) , G01N 33/564 (2006.01) | | Title | DIABETESBIOMARKØRER | | Int. application no. | US2013042627 | | Int. publication no. | WO2013177505 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
